CCCC

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

C4 Therapeutics Inc

NASDAQ | CCCC

2.37

USD

$0.00

(

0.00%

)

At Close (As of Oct 17, 2025)

$220.18M

Market Cap

-

P/E Ratio

-1.59

EPS

$6.52

52 Week High

$1.08

52 Week Low

HEALTHCARE

Sector

CCCC Chart

Recent Chart
Price Action

CCCC Technicals

Tags:

CCCC Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $36M
Total Revenue $36M
Cost Of Revenue $7.9M
Costof Goods And Services Sold $7.9M
Operating Income -$120M
Selling General And Administrative $42M
Research And Development $111M
Operating Expenses $155M
Investment Income Net -
Net Interest Income $14M
Interest Income $14M
Interest Expense $0
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.8M
Income Before Tax -$105M
Income Tax Expense $131K
Interest And Debt Expense -
Net Income From Continuing Operations -$105M
Comprehensive Income Net Of Tax -
Ebit -$105M
Ebitda -$103M
Net Income -$105M

Revenue & Profitability

Earnings Performance

CCCC Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $350M
Total Current Assets $258M
Cash And Cash Equivalents At Carrying Value $55M
Cash And Short Term Investments $55M
Inventory -
Current Net Receivables $3.1M
Total Non Current Assets $92M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments $22M
Short Term Investments $189M
Other Current Assets $9.8M
Other Non Current Assets -
Total Liabilities $134M
Total Current Liabilities $45M
Current Accounts Payable $1.3M
Deferred Revenue -
Current Debt -
Short Term Debt $5.8M
Total Non Current Liabilities $88M
Capital Lease Obligations $66M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $66M
Other Current Liabilities $19M
Other Non Current Liabilities -
Total Shareholder Equity $216M
Treasury Stock -
Retained Earnings -$634M
Common Stock $7K
Common Stock Shares Outstanding $69M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$65M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $1.8M
Capital Expenditures $180K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$51M
Cashflow From Financing $45M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$194K
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$105M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $36M
Total Revenue $36M
Cost Of Revenue $7.9M
Costof Goods And Services Sold $7.9M
Operating Income -$120M
Selling General And Administrative $42M
Research And Development $111M
Operating Expenses $155M
Investment Income Net -
Net Interest Income $14M
Interest Income $14M
Interest Expense $0
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.8M
Income Before Tax -$105M
Income Tax Expense $131K
Interest And Debt Expense -
Net Income From Continuing Operations -$105M
Comprehensive Income Net Of Tax -
Ebit -$105M
Ebitda -$103M
Net Income -$105M

CCCC News

CCCC Profile

C4 Therapeutics Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

C4 Therapeutics, Inc. is a pioneering biopharmaceutical company headquartered in Watertown, Massachusetts, dedicated to advancing novel therapeutic candidates that target and eradicate disease-causing proteins. With a strong emphasis on oncology and neurodegenerative diseases, the firm's proprietary dynamic protein degradation platform employs cutting-edge biological mechanisms to deliver transformative treatment options for patients facing unmet medical needs. Positioned at the forefront of the biopharmaceutical sector, C4 Therapeutics is committed to enhancing patient outcomes through innovative and groundbreaking therapies that redefine treatment paradigms.

VHAI
-25.00%
$0.00
RANI
+248.26%
$1.64
BYND
+24.15%
$0.64
YYAI
+0.83%
$0.12
YDKG
-40.50%
$0.05
CGBS
-39.47%
$0.03
BITF
-5.11%
$5.01
NVDA
+0.77%
$183.22
INTC
+0.46%
$37.01
RGTI
-3.31%
$46.38
GDXD
+20.23%
$0.72
F
+1.53%
$11.92
PLUG
-2.29%
$3.40
ARTV
+116.96%
$6.01
BURU
+0.85%
$0.34
TSLA
+2.46%
$439.31
DNN
-5.50%
$2.92
BBD
+1.22%
$3.30
IONZ
+7.55%
$3.70
HBAN
+0.84%
$15.50
NIO
-1.17%
$6.75
CAN
-4.19%
$1.60
NVTS
-6.20%
$14.66
HIMS
-15.84%
$49.78
RXRX
-7.86%
$5.86
TLRY
+1.29%
$1.56
AXDX
-61.36%
$0.03
BTG
-6.56%
$5.55
HPE
+2.04%
$22.96
LAES
+4.87%
$6.67
RGTZ
+6.58%
$11.97
T
+0.53%
$26.34
ETHD
+2.25%
$4.09
ELBM
+35.36%
$2.22
BLMZ
-3.85%
$0.18
ACHR
-5.30%
$11.24
AMD
-0.63%
$233.08
WTO
-47.99%
$0.07
CIFR
+0.21%
$18.76
KVUE
+8.36%
$15.29
GNPX
-23.68%
$0.36
LNKS
+30.35%
$0.73
RIG
+0.92%
$3.26
GPUS
-11.96%
$0.32
MARA
-3.42%
$19.57
AAPL
+1.95%
$252.29
BAC
+1.66%
$51.28
SOFI
-0.22%
$26.54
JOBY
-2.55%
$15.66
SOUN
-8.38%
$19.02
RF
+0.98%
$23.58
AMZN
-0.66%
$213.04
QBTS
-5.26%
$38.33
PLTR
+0.01%
$178.15
EPWK
-18.45%
$0.07
ONDS
-7.19%
$7.61
GRAB
-1.22%
$5.64
QUBT
-2.18%
$18.32
ADAP
+2.51%
$0.20
PFE
+1.15%
$24.51
RMBL
+60.50%
$3.21
SLB
-0.88%
$32.63
BMNR
-2.40%
$49.85
ABEV
+0.89%
$2.25
IREN
-1.79%
$60.72
ASST
-7.28%
$0.83
ADD
-25.47%
$0.05
SNAP
-1.41%
$7.65
ORCL
-6.92%
$291.31
CRML
+7.41%
$20.86
DFLI
+2.25%
$1.36
BTBT
-1.08%
$3.65
VIVK
-29.17%
$0.20
SRM
+53.27%
$10.30
AAL
-0.25%
$11.86
NUAI
+44.44%
$4.55
NEHC
+44.44%
$4.55
IONQ
-4.04%
$62.94
WULF
+0.50%
$13.93
NAK
-8.48%
$2.04
NOK
+1.05%
$5.74
ATAI
+17.70%
$6.45
RR
-4.05%
$5.44
SMR
-7.11%
$44.25
CLSK
-2.32%
$19.52
GWH
+16.04%
$5.28
APLD
-6.55%
$34.24
CRWV
-3.43%
$136.87
YGMZ
-6.12%
$0.92
UUUU
-2.90%
$21.06
QS
-0.64%
$15.36
GOOGL
+0.73%
$253.30
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
VALE
-0.09%
$11.10
WLGS
-5.57%
$0.04
FNB
+3.00%
$15.09
BULL
-6.29%
$11.01
AG
-8.48%
$14.03
FEMY
-5.67%
$0.70
VHAI
-25.00%
$0.00
RANI
+248.26%
$1.64
BYND
+24.15%
$0.64
YYAI
+0.83%
$0.12
YDKG
-40.50%
$0.05
CGBS
-39.47%
$0.03
BITF
-5.11%
$5.01
NVDA
+0.77%
$183.22
INTC
+0.46%
$37.01
RGTI
-3.31%
$46.38
GDXD
+20.23%
$0.72
F
+1.53%
$11.92
PLUG
-2.29%
$3.40
ARTV
+116.96%
$6.01
BURU
+0.85%
$0.34
TSLA
+2.46%
$439.31
DNN
-5.50%
$2.92
BBD
+1.22%
$3.30
IONZ
+7.55%
$3.70
HBAN
+0.84%
$15.50
NIO
-1.17%
$6.75
CAN
-4.19%
$1.60
NVTS
-6.20%
$14.66
HIMS
-15.84%
$49.78
RXRX
-7.86%
$5.86
TLRY
+1.29%
$1.56
AXDX
-61.36%
$0.03
BTG
-6.56%
$5.55
HPE
+2.04%
$22.96
LAES
+4.87%
$6.67
RGTZ
+6.58%
$11.97
T
+0.53%
$26.34
ETHD
+2.25%
$4.09
ELBM
+35.36%
$2.22
BLMZ
-3.85%
$0.18
ACHR
-5.30%
$11.24
AMD
-0.63%
$233.08
WTO
-47.99%
$0.07
CIFR
+0.21%
$18.76
KVUE
+8.36%
$15.29
GNPX
-23.68%
$0.36
LNKS
+30.35%
$0.73
RIG
+0.92%
$3.26
GPUS
-11.96%
$0.32
MARA
-3.42%
$19.57
AAPL
+1.95%
$252.29
BAC
+1.66%
$51.28
SOFI
-0.22%
$26.54
JOBY
-2.55%
$15.66
SOUN
-8.38%
$19.02
RF
+0.98%
$23.58
AMZN
-0.66%
$213.04
QBTS
-5.26%
$38.33
PLTR
+0.01%
$178.15
EPWK
-18.45%
$0.07
ONDS
-7.19%
$7.61
GRAB
-1.22%
$5.64
QUBT
-2.18%
$18.32
ADAP
+2.51%
$0.20
PFE
+1.15%
$24.51
RMBL
+60.50%
$3.21
SLB
-0.88%
$32.63
BMNR
-2.40%
$49.85
ABEV
+0.89%
$2.25
IREN
-1.79%
$60.72
ASST
-7.28%
$0.83
ADD
-25.47%
$0.05
SNAP
-1.41%
$7.65
ORCL
-6.92%
$291.31
CRML
+7.41%
$20.86
DFLI
+2.25%
$1.36
BTBT
-1.08%
$3.65
VIVK
-29.17%
$0.20
SRM
+53.27%
$10.30
AAL
-0.25%
$11.86
NUAI
+44.44%
$4.55
NEHC
+44.44%
$4.55
IONQ
-4.04%
$62.94
WULF
+0.50%
$13.93
NAK
-8.48%
$2.04
NOK
+1.05%
$5.74
ATAI
+17.70%
$6.45
RR
-4.05%
$5.44
SMR
-7.11%
$44.25
CLSK
-2.32%
$19.52
GWH
+16.04%
$5.28
APLD
-6.55%
$34.24
CRWV
-3.43%
$136.87
YGMZ
-6.12%
$0.92
UUUU
-2.90%
$21.06
QS
-0.64%
$15.36
GOOGL
+0.73%
$253.30
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
VALE
-0.09%
$11.10
WLGS
-5.57%
$0.04
FNB
+3.00%
$15.09
BULL
-6.29%
$11.01
AG
-8.48%
$14.03
FEMY
-5.67%
$0.70
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.